Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $550 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $550.
July 13, 2023 | 12:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly has received an Overweight rating from Cantor Fitzgerald, with a maintained price target of $550.
The Overweight rating from Cantor Fitzgerald indicates a positive outlook for Eli Lilly. The maintained price target of $550 suggests that the analyst believes the stock has potential for significant growth. This could lead to increased investor interest and a potential rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100